Bernard Siegel to Address the World Congress for Freedom of Scientific Research in Rome, Italy

WASHINGTON, DC, March 31, 2014 (GLOBE NEWSWIRE) -- The Genetics Policy Institute (GPI) announced today that Bernard Siegel, founder and executive director of GPI and chair of the Stem Cell Action Coalition, will provide a policy address titled, "Past, Present and Future – The Impact of the Patient Advocacy Movement on Regenerative Medicine" at the Third World Congress for Freedom of Scientific Research to be held April 4-6 at the Italian Chamber of Deputies and at the Capitoline Hill in Rome, Italy. The Congress proceedings are under the patronage of the Italian Ministry of Foreign Affairs, the Ministry of Health and the City of Rome.

The Congress' theme is "Bridging the Gap Between Science and Politics." Among the dignitaries attending and providing remarks are the program chair, Roberto Giachetti, Vice President of the Italian Chamber of Deputies; Giorgio Napolitano, President of the Italian Republic, and Pietro Grasso, President of the Senate of the Italian Republic.

The World Congress of Freedom of Scientific Research brings together some of the leading thought-leaders in the fields of science, ethics, policy, law and advocacy. Bernard Siegel, GPI executive director, stated, "The aim of the Congress is to facilitate a societal framework to accelerate science targeting cures and removing unreasonable political roadblocks. As a champion of the life sciences, I am honored to be one of the voices of patient advocacy at this historic event."

Bernard Siegel, J.D., is the founder and executive director of the nonprofit Genetics Policy Institute (GPI) based in Palm Beach, Florida. He is the founder and co-chair of the World Stem Cell Summit series of global conferences and editor-in-chief of the World Stem Cell Report and 360 Stem Cell & Regenerative Medicine Newsletter.  He chairs the Stem Cell Action Coalition, a  100+ member global partnership of societies of science and medicine, medical philanthropies, academic institutions and patient advocacy groups.
About Genetics Policy Institute (GPI): GPI was formed in 2003 with the mission of promoting and defending stem cell research and its application in medicine to develop therapeutics and cures for many otherwise intractable diseases and disorders. GPI pursues this mission through production and management of its flagship annual World Stem Cell Summit, publication of the World Stem Cell Report, special projects such as the Stem Cell Action Coalition, speaking engagements, teaching initiatives, and strategic collaborations. For more information about GPI, visit our website at GPI's 10th anniversary World Stem Cell Summit will be held at San Antonio, Texas (USA) on December 3-5, 2014. Learn more at


Contact Data